Openedges Technology, Inc. Logo

Openedges Technology, Inc.

Semiconductor IP provider of memory subsystem & AI platform IP for AI, HPC, and IoT SoCs.

394280 | KO

Overview

Corporate Details

ISIN(s):
KR7394280002
LEI:
Country:
South Korea
Address:
서울특별시 강남구 역삼로 114 현죽빌딩 13층, 서울특별시
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Openedges Technology, Inc. is a semiconductor intellectual property (IP) provider specializing in integrated solutions for artificial intelligence and high-performance computing. The company positions itself as a leading provider of a total memory subsystem and AI platform IP. Its product portfolio includes a range of solutions such as DDR memory controllers, DDR PHY, Network-on-Chip (NoC) interconnects, and Neural Processing Unit (NPU) IPs. These components are designed to enable efficient data processing for applications in AI, smart computing, and the Internet of Things (IoT). Founded in 2017, Openedges supplies essential modules for semiconductor companies developing advanced systems-on-chip (SoCs).

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-18 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 29.3 KB
2025-09-18 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 27.7 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.3 MB
2025-08-14 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.8 KB
2025-08-05 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.9 KB
2025-07-31 00:00
Share Issue/Capital Change
전환주식의전환가액조정
Korean 12.2 KB
2025-07-18 00:00
Major Shareholding Notification
[기재정정]주식등의대량보유상황보고서(일반)
Korean 200.6 KB
2025-07-18 00:00
Major Shareholding Notification
[기재정정]주식등의대량보유상황보고서(일반)
Korean 133.0 KB
2025-07-18 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 157.9 KB
2025-07-14 00:00
Regulatory News Service
단일판매ㆍ공급계약체결
Korean 10.4 KB
2025-07-01 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 27.2 KB
2025-06-27 00:00
Regulatory News Service
단일판매ㆍ공급계약체결(자율공시)
Korean 10.0 KB
2025-06-17 00:00
Regulatory News Service
[기재정정]단일판매ㆍ공급계약체결
Korean 14.3 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 972.4 KB
2025-05-15 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 24.3 KB

Automate Your Workflow. Get a real-time feed of all Openedges Technology, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Openedges Technology, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Openedges Technology, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Qurient Co., Ltd. Logo
Biopharma developing novel drugs for cancer, inflammation, and infectious diseases.
South Korea
115180
Rafael Holdings, Inc. Logo
Invests in and develops novel therapeutics for cancer and rare diseases.
United States of America
RFL
RaQualia Pharma Inc. Logo
An R&D firm discovering novel small molecules for out-licensing to pharma partners.
Japan
4579
Recruit Holdings Co., Ltd. Logo
Global provider of HR tech (Indeed), staffing services, and business SaaS solutions.
Japan
6098
RELMADA THERAPEUTICS, INC. Logo
A clinical-stage biotech developing novel therapies for CNS diseases and oncology.
United States of America
RLMD
Renascience Inc. Logo
Develops innovative drugs and AI-powered medical devices for aging and hereditary diseases.
Japan
4889
Rentracks CO.,LTD. Logo
A pay-per-performance ad network with a closed ASP and comprehensive web consulting services.
Japan
6045
Replimune Group, Inc. Logo
Clinical-stage biotech developing oncolytic immunotherapies to treat a broad range of cancers.
United States of America
REPL
ReproCELL Incorporated Logo
Offers stem cell tech, gene editing & drug discovery services for preclinical/clinical research.
Japan
4978
RESEARCH FRONTIERS INC Logo
Develops and licenses smart glass tech for instant light, UV, and heat control.
United States of America
REFR

Talk to a Data Expert

Have a question? We'll get back to you promptly.